News Wow of the Week: A potential breakthrough toward a cure for type 1 diabetes – MedCity News Boston Children’s Hospital stirred up some buzz this week when it said its researchers had made a breakthrough that could…Super UserJune 24, 2013
News D.C. ranks among top 10 cities for venture capital – Washington Business Journal Silicon Valley has long been the epicenter of venture capital-financed high-technology, but a new report shows D.C. is climbing the…Super UserJune 24, 2013
News Report Published: “MedImmune, LLC – Product Pipeline Review – 2013” Global Market Direct's pharmaceuticals report, "MedImmune, LLC - Product Pipeline Review - 2013" provides data on the MedImmune, LLC's research…Super UserJune 24, 2013
News WellDoc hopes to double revenue through new diabetes app – Baltimore Business Journal Baltimore health IT firm WellDoc expects a new diabetes management tool to help the company double its annual revenue and…Super UserJune 21, 2013
News Enhanced Search Engine for Available Technologies – FLC Last fall, the Federal Laboratory Consortium for Technology Transfer introduced an improved Available Technologies search tool that made it faster…Super UserJune 21, 2013
News A Toast to the Generalist – Asian Fortune This is the season of inaugurations and internships, with the class of 2014 college grads starting a new chapter in…Super UserJune 21, 2013
News Johns Hopkins student-built devices win two top awards in national contest Johns Hopkins student-built devices—a blood clot detection system and a concealable, hands-free breast pump—have won two of the top three…Super UserJune 21, 2013
News Young VC firm Cultivation Capital jumps right into early stage life sciences funding with $30M | MedCity News The emerging tech town of St. Louis has also become fertile ground for a community of life sciences companies that…Super UserJune 21, 2013
News 3-V Biosciences Completes $20 Million Series C Financing – PR Newswire – The Sacramento Bee 3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today announced the…Super UserJune 21, 2013
News GlaxoSmithKline invests EUR17.5m in French venture for rare diseases – Pharmaceutical Business Review UK-based healthcare company GlaxoSmithKline (GSK) has announced an investment of €17.5m ($23.5m) in a French venture firm to develop new…Super UserJune 21, 2013